AQP4 and neuromuscular disease caused by qualitative or quantitative defects of dysferlin: While AQP4 reduction in FCMD correlates with reduced α-syntrophin in the muscle, immunostaining for α1-syntrophin is unchanged in dysferlinopathy patients, suggesting a distinct mechanism involved [80,81].